Related articles on growth, operations, and the systems shaping modern medical aesthetics practices
World Psychiatry 21 , 124132 (2022)
By the time the same topic was discussed at the 2025 World Conference on Doping in Sport, WADAs Health, Medical and Research Committee had commissioned targeted research into whether semaglutide has performance-enhancing effects, and hence whether an entirely new prohibited substance category for weight-management substances should be established
When managed properly in a medically supervised scenario, this formulation may offer: Enhanced metabolic regulation: By engaging both the GIP and GLP-1 receptors, tirzepatide can support greater insulin sensitivity, reduced appetite, and weight-loss potential
Other GLP-1 RAs like liraglutide (Saxenda) and dulaglutide (Trulicity) also exist, but semaglutide and tirzepatide have garnered the most attention due to their potency in weight reduction
Both pathways are relevant to ipamorelin because the peptide still depends on the pituitary's ability to respond to GHS-R1a activation